Bispecific Antibodies Drug Market
1 Bispecific Antibodies Drug Market Overview
1.1 Product Overview and Scope of Bispecific Antibodies Drug
1.2 Bispecific Antibodies Drug Segment by Type
1.2.1 Global Bispecific Antibodies Drug Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Blincyto
1.2.3 Kimmtrak
1.2.4 Hemlibra
1.3 Bispecific Antibodies Drug Segment by Application
1.3.1 Global Bispecific Antibodies Drug Sales Comparison by Application: (2022-2028)
1.3.2 Hematological Cancers
1.3.3 Solid Tumors
1.4 Global Bispecific Antibodies Drug Market Size Estimates and Forecasts
1.4.1 Global Bispecific Antibodies Drug Revenue 2017-2028
1.4.2 Global Bispecific Antibodies Drug Sales 2017-2028
1.4.3 Bispecific Antibodies Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Bispecific Antibodies Drug Market Competition by Manufacturers
2.1 Global Bispecific Antibodies Drug Sales Market Share by Manufacturers (2017-2022)
2.2 Global Bispecific Antibodies Drug Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Bispecific Antibodies Drug Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Bispecific Antibodies Drug Manufacturing Sites, Area Served, Product Type
2.5 Bispecific Antibodies Drug Market Competitive Situation and Trends
2.5.1 Bispecific Antibodies Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Bispecific Antibodies Drug Players Market Share by Revenue
2.5.3 Global Bispecific Antibodies Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bispecific Antibodies Drug Retrospective Market Scenario by Region
3.1 Global Bispecific Antibodies Drug Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Bispecific Antibodies Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Bispecific Antibodies Drug Market Facts & Figures by Country
3.3.1 North America Bispecific Antibodies Drug Sales by Country
3.3.2 North America Bispecific Antibodies Drug Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Bispecific Antibodies Drug Market Facts & Figures by Country
3.4.1 Europe Bispecific Antibodies Drug Sales by Country
3.4.2 Europe Bispecific Antibodies Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Bispecific Antibodies Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Bispecific Antibodies Drug Sales by Region
3.5.2 Asia Pacific Bispecific Antibodies Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Bispecific Antibodies Drug Market Facts & Figures by Country
3.6.1 Latin America Bispecific Antibodies Drug Sales by Country
3.6.2 Latin America Bispecific Antibodies Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Bispecific Antibodies Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Bispecific Antibodies Drug Sales by Country
3.7.2 Middle East and Africa Bispecific Antibodies Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Bispecific Antibodies Drug Historic Market Analysis by Type
4.1 Global Bispecific Antibodies Drug Sales Market Share by Type (2017-2022)
4.2 Global Bispecific Antibodies Drug Revenue Market Share by Type (2017-2022)
4.3 Global Bispecific Antibodies Drug Price by Type (2017-2022)
5 Global Bispecific Antibodies Drug Historic Market Analysis by Application
5.1 Global Bispecific Antibodies Drug Sales Market Share by Application (2017-2022)
5.2 Global Bispecific Antibodies Drug Revenue Market Share by Application (2017-2022)
5.3 Global Bispecific Antibodies Drug Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Bispecific Antibodies Drug Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Amgen Bispecific Antibodies Drug Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Immunocore
6.2.1 Immunocore Corporation Information
6.2.2 Immunocore Description and Business Overview
6.2.3 Immunocore Bispecific Antibodies Drug Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Immunocore Bispecific Antibodies Drug Product Portfolio
6.2.5 Immunocore Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Bispecific Antibodies Drug Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Roche Bispecific Antibodies Drug Product Portfolio
6.3.5 Roche Recent Developments/Updates
7 Bispecific Antibodies Drug Manufacturing Cost Analysis
7.1 Bispecific Antibodies Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Bispecific Antibodies Drug
7.4 Bispecific Antibodies Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Bispecific Antibodies Drug Distributors List
8.3 Bispecific Antibodies Drug Customers
9 Bispecific Antibodies Drug Market Dynamics
9.1 Bispecific Antibodies Drug Industry Trends
9.2 Bispecific Antibodies Drug Market Drivers
9.3 Bispecific Antibodies Drug Market Challenges
9.4 Bispecific Antibodies Drug Market Restraints
10 Global Market Forecast
10.1 Bispecific Antibodies Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Bispecific Antibodies Drug by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Bispecific Antibodies Drug by Type (2023-2028)
10.2 Bispecific Antibodies Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Bispecific Antibodies Drug by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Bispecific Antibodies Drug by Application (2023-2028)
10.3 Bispecific Antibodies Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Bispecific Antibodies Drug by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Bispecific Antibodies Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Bispecific Antibodies Drug Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
Table 2. Global Bispecific Antibodies Drug Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
Table 3. Global Bispecific Antibodies Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Bispecific Antibodies Drug Market Competitive Situation by Manufacturers in 2021
Table 5. Global Bispecific Antibodies Drug Sales (Units) of Key Manufacturers (2017-2022)
Table 6. Global Bispecific Antibodies Drug Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Bispecific Antibodies Drug Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Bispecific Antibodies Drug Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Bispecific Antibodies Drug Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Bispecific Antibodies Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Bispecific Antibodies Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Bispecific Antibodies Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bispecific Antibodies Drug as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Bispecific Antibodies Drug Sales by Region (2017-2022) & (Units)
Table 16. Global Bispecific Antibodies Drug Sales Market Share by Region (2017-2022)
Table 17. Global Bispecific Antibodies Drug Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Bispecific Antibodies Drug Revenue Market Share by Region (2017-2022)
Table 19. North America Bispecific Antibodies Drug Sales by Country (2017-2022) & (Units)
Table 20. North America Bispecific Antibodies Drug Sales Market Share by Country (2017-2022)
Table 21. North America Bispecific Antibodies Drug Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Bispecific Antibodies Drug Revenue Market Share by Country (2017-2022)
Table 23. Europe Bispecific Antibodies Drug Sales by Country (2017-2022) & (Units)
Table 24. Europe Bispecific Antibodies Drug Sales Market Share by Country (2017-2022)
Table 25. Europe Bispecific Antibodies Drug Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Bispecific Antibodies Drug Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Bispecific Antibodies Drug Sales by Region (2017-2022) & (Units)
Table 28. Asia Pacific Bispecific Antibodies Drug Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Bispecific Antibodies Drug Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Bispecific Antibodies Drug Revenue Market Share by Region (2017-2022)
Table 31. Latin America Bispecific Antibodies Drug Sales by Country (2017-2022) & (Units)
Table 32. Latin America Bispecific Antibodies Drug Sales Market Share by Country (2017-2022)
Table 33. Latin America Bispecific Antibodies Drug Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Bispecific Antibodies Drug Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Bispecific Antibodies Drug Sales by Country (2017-2022) & (Units)
Table 36. Middle East and Africa Bispecific Antibodies Drug Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Bispecific Antibodies Drug Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Bispecific Antibodies Drug Revenue Market Share by Country (2017-2022)
Table 39. Global Bispecific Antibodies Drug Sales by Type (2017-2022) & (Units)
Table 40. Global Bispecific Antibodies Drug Sales Market Share by Type (2017-2022)
Table 41. Global Bispecific Antibodies Drug Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Bispecific Antibodies Drug Revenue Share by Type (2017-2022)
Table 43. Global Bispecific Antibodies Drug Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Bispecific Antibodies Drug Sales (Units) by Application (2017-2022)
Table 45. Global Bispecific Antibodies Drug Sales Market Share by Application (2017-2022)
Table 46. Global Bispecific Antibodies Drug Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Bispecific Antibodies Drug Revenue Share by Application (2017-2022)
Table 48. Global Bispecific Antibodies Drug Price by Application (2017-2022) & (US$/Unit)
Table 49. Amgen Corporation Information
Table 50. Amgen Description and Business Overview
Table 51. Amgen Bispecific Antibodies Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Amgen Bispecific Antibodies Drug Product
Table 53. Amgen Recent Developments/Updates
Table 54. Immunocore Corporation Information
Table 55. Immunocore Description and Business Overview
Table 56. Immunocore Bispecific Antibodies Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Immunocore Bispecific Antibodies Drug Product
Table 58. Immunocore Recent Developments/Updates
Table 59. Roche Corporation Information
Table 60. Roche Description and Business Overview
Table 61. Roche Bispecific Antibodies Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Roche Bispecific Antibodies Drug Product
Table 63. Roche Recent Developments/Updates
Table 64. Production Base and Market Concentration Rate of Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Bispecific Antibodies Drug Distributors List
Table 67. Bispecific Antibodies Drug Customers List
Table 68. Bispecific Antibodies Drug Market Trends
Table 69. Bispecific Antibodies Drug Market Drivers
Table 70. Bispecific Antibodies Drug Market Challenges
Table 71. Bispecific Antibodies Drug Market Restraints
Table 72. Global Bispecific Antibodies Drug Sales Forecast by Type (2023-2028) & (Units)
Table 73. Global Bispecific Antibodies Drug Sales Market Share Forecast by Type (2023-2028)
Table 74. Global Bispecific Antibodies Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 75. Global Bispecific Antibodies Drug Revenue Market Share Forecast by Type (2023-2028)
Table 76. Global Bispecific Antibodies Drug Sales Forecast by Application (2023-2028) & (Units)
Table 77. Global Bispecific Antibodies Drug Sales Market Share Forecast by Application (2023-2028)
Table 78. Global Bispecific Antibodies Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 79. Global Bispecific Antibodies Drug Revenue Market Share Forecast by Application (2023-2028)
Table 80. Global Bispecific Antibodies Drug Sales Forecast by Region (2023-2028) & (Units)
Table 81. Global Bispecific Antibodies Drug Sales Market Share Forecast by Region (2023-2028)
Table 82. Global Bispecific Antibodies Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 83. Global Bispecific Antibodies Drug Revenue Market Share Forecast by Region (2023-2028)
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bispecific Antibodies Drug
Figure 2. Global Bispecific Antibodies Drug Market Share by Type in 2021 & 2028
Figure 3. Blincyto Product Picture
Figure 4. Kimmtrak Product Picture
Figure 5. Hemlibra Product Picture
Figure 6. Global Bispecific Antibodies Drug Market Share by Application in 2021 & 2028
Figure 7. Hematological Cancers
Figure 8. Solid Tumors
Figure 9. Global Bispecific Antibodies Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Bispecific Antibodies Drug Market Size (2017-2028) & (US$ Million)
Figure 11. Global Bispecific Antibodies Drug Sales (2017-2028) & (Units)
Figure 12. Bispecific Antibodies Drug Sales Share by Manufacturers in 2021
Figure 13. Global Bispecific Antibodies Drug Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Bispecific Antibodies Drug Players: Market Share by Revenue in 2021
Figure 15. Bispecific Antibodies Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Bispecific Antibodies Drug Sales Market Share by Region (2017-2022)
Figure 17. Global Bispecific Antibodies Drug Sales Market Share by Region in 2021
Figure 18. Global Bispecific Antibodies Drug Revenue Market Share by Region (2017-2022)
Figure 19. Global Bispecific Antibodies Drug Revenue Market Share by Region in 2021
Figure 20. United States Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Bispecific Antibodies Drug by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Bispecific Antibodies Drug
Figure 44. Manufacturing Process Analysis of Bispecific Antibodies Drug
Figure 45. Bispecific Antibodies Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Industry Market Size
